文献速递糖尿病

2型糖尿病与血糖稳态受损的胃肠道后果:一项孟德尔随机化研究

Gastrointestinal Consequences of Type 2 Diabetes Mellitus and Impaired Glycemic Homeostasis: A Mendelian Randomization Study.
PubMed 文献 · Diabetes Care · 2023-01-01

该孟德尔随机化研究利用与2型糖尿病(231个)、空腹胰岛素(38个)、空腹血糖(71个)和糖化血红蛋白(75个)相关的遗传变异作为工具变量,评估其与23种常见胃肠道疾病的关联。结果显示,2型糖尿病遗传易感性与12种胃肠道疾病风险相关,空腹胰岛素和空腹血糖分别与6种和1种胃肠道疾病相关。

要点

  • 2型糖尿病遗传易感性与胃食管反流病、胃溃疡、急性胃炎、慢性胃炎、肠易激综合征、憩室病、急性胰腺炎、胆石症、胆石症伴胆囊炎、非酒精性脂肪性肝病、肝硬化和溃疡性结肠炎的风险相关。
  • 2型糖尿病对数优势比每增加1单位,非酒精性脂肪性肝病的OR为1.29(95%CI 1.17-1.43),溃疡性结肠炎的OR为0.93(95%CI 0.89-0.97)。
  • 遗传预测的空腹胰岛素和空腹血糖水平分别与6种和1种胃肠道疾病相关。

核心结论

  • 遗传易感的2型糖尿病与多种胃肠道疾病风险增加相关,强调2型糖尿病患者预防胃肠道疾病的重要性。

研究设计与样本

  • 孟德尔随机化研究,选取与2型糖尿病(n=231)、空腹胰岛素(n=38)、空腹血糖(n=71)和糖化血红蛋白(n=75)在全基因组显著性水平相关的非相关遗传变异作为工具变量。
  • 23种常见胃肠道疾病的遗传关联数据来自FinnGen、UK Biobank研究及其他大型联盟。

主要发现

  • 2型糖尿病遗传易感性与12种胃肠道疾病风险相关:2型糖尿病对数优势比每增加1单位,胃食管反流病OR为1.06(95%CI 1.03-1.09),胃溃疡OR为1.12(95%CI 1.07-1.17),急性胃炎OR为1.11(95%CI 1.03-1.20),慢性胃炎OR为1.07(95%CI 1.01-1.13),肠易激综合征OR为1.08(95%CI 1.03-1.12),憩室病OR为1.04(95%CI 1.01-1.07),急性胰腺炎OR为1.08(95%CI 1.02-1.14),胆石症OR为1.09(95%CI 1.05-1.12),胆石症伴胆囊炎OR为1.09(95%CI 1.05-1.13),非酒精性脂肪性肝病OR为1.29(95%CI 1.17-1.43),肝硬化OR为1.12(95%CI 1.03-1.21),溃疡性结肠炎OR为0.93(95%CI 0.89-0.97)。
  • 遗传预测的空腹胰岛素水平升高与6种胃肠道疾病相关,遗传预测的空腹血糖水平升高与1种胃肠道疾病相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We conducted a Mendelian randomization (MR) study to examine the associations of type 2 diabetes and glycemic traits with gastrointestinal diseases (GDs). RESEARCH DESIGN AND METHODS: Uncorrelated genetic variants associated with type 2 diabetes (n = 231), fasting insulin (n = 38), fasting glucose (n = 71), and hemoglobin A1c (n = 75) at the genome-wide significance were selected as instrument variables. Genetic associations with 23 common GDs were obtained from the FinnGen and UK Biobank studies and other large consortia. RESULTS: Genetic liability to type 2 diabetes was associated with the risk of 12 GDs. Per 1-unit increase in the log-transformed odds ratio (OR) of type 2 diabetes, the OR was 1.06 (95% CI, 1.03-1.09) for gastroesophageal reflux disease, 1.12 (95% CI, 1.07-1.17) for gastric ulcer, 1.11 (95% CI, 1.03-1.20) for acute gastritis, 1.07 (95% CI, 1.01-1.13) for chronic gastritis, 1.08 (95% CI, 1.03-1.12) for irritable bowel syndrome, 1.04 (95% CI, 1.01-1.07) for diverticular disease, 1.08 (95% CI, 1.02-1.14) for acute pancreatitis, 1.09 (95% CI, 1.05-1.12) for cholelithiasis, 1.09 (95% CI, 1.05-1.13) for cholelithiasis with cholecystitis, 1.29 (95% CI, 1.17-1.43) for nonalcoholic fatty liver disease, 1.12 (95% CI, 1.03-1.21) for liver cirrhosis, and 0.93 (95% CI, 0.89-0.97) for ulcerative colitis. Genetically predicted higher levels of fasting insulin and glucose were associated with six and one GDs, respectively. CONCLUSIONS: Associations were found between genetic liability to type 2 diabetes and an increased risk of a broad range of GDs, highlighting the importance of GD prevention in patients with type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Chen J, Yuan S, Fu T, et al. Gastrointestinal Consequences of Type 2 Diabetes Mellitus and Impaired Glycemic Homeostasis: A Mendelian Randomization Study. Diabetes Care. 2023. PMID: 36800530. doi:10.2337/dc22-1385

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。